Texas Instruments (Nasdaq: TXN ) is expected to report Q1 earnings on April 22. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Texas Instruments's revenues will wane -8.6% and EPS will drop 0.0%.
The average estimate for revenue is $2.85 billion. On the bottom line, the average EPS estimate is $0.32.
Last quarter, Texas Instruments chalked up revenue of $2.98 billion. GAAP reported sales were 13% lower than the prior-year quarter's $3.42 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.36. GAAP EPS of $0.23 for Q4 were 8.0% lower than the prior-year quarter's $0.25 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 48.5%, 20 basis points better than the prior-year quarter. Operating margin was 14.9%, 660 basis points worse than the prior-year quarter. Net margin was 8.9%, 20 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $12.17 billion. The average EPS estimate is $1.75.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 1,538 members out of 1,666 rating the stock outperform, and 128 members rating it underperform. Among 388 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 368 give Texas Instruments a green thumbs-up, and 20 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Texas Instruments is hold, with an average price target of $29.46.
Is Texas Instruments the best semiconductor stock for you? You may be missing something obvious. Check out the semiconductor company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add Texas Instruments to My Watchlist.